Samina Ahmed, MD
Hematology/Oncology · Anaheim
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Southern California Permanente Medical Group · 11,250 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ahmed’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A103776 · Current
Licensed to practise in California · since 2008 · expires 2027-11-30 · Rush Medical College of Rush University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$19,334
Medicare paid this office $19,334 for 11 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
11 Original Medicare patients in 2024. Average age 67 · 85 and older 0% · Health risk score 2.52. Above the middle of the specialty; the typical hematology-oncology clinician is at 2.04.
The office billed $114,639, Medicare allowed $24,607 and paid $19,334; for 985 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 11 | 985 | 67 | 2.52 | $114,639 | $19,334 |
| 2023 | 11 | 3,143 | 62 | 2.13 | $221,005 | $46,178 |
| 2022 | 13 | 1,507 | 68 | 2.47 | $140,212 | $35,936 |
| 2018 | 12 | 1,162 | 59 | 3.26 | $62,225 | $14,270 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
Medicaid work
$15,964 in 2024
Medicaid paid $15,964 for 557 billed services this clinician did in 2024, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour | 107 | $11,123 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 12 | $3,728 |
| Infusion, normal saline solution , 1000 cc | 438 | $1,113 |
| 2024 | 557 | 3 | 42 | $15,964 |
| 2023 | 84 | 1 | 17 | $31 |
See the largest Medicaid services in earlier years
2023
| Infusion, normal saline solution , 1000 cc | 84 | $31 |
Drugs they prescribed that Part D paid
$5,365,238
Pharmacies billed $5,365,238 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (13 of 1,510) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%.
1,143 generic and 367 brand-name prescriptions · $5,365,238 in drug cost · 13 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ibrance | 62 | $960,665 | $15,495 |
| Kisqali | 45 | $706,218 | $15,694 |
| Lenalidomide | 58 | $666,318 | $11,488 |
| Tagrisso | 46 | $663,144 | $14,416 |
| Brukinsa | 39 | $512,632 | $13,144 |
See all 30 drugs
| Ibrance | 62 | $960,665 | $15,495 |
| Kisqali | 45 | $706,218 | $15,694 |
| Lenalidomide | 58 | $666,318 | $11,488 |
| Tagrisso | 46 | $663,144 | $14,416 |
| Brukinsa | 39 | $512,632 | $13,144 |
| Calquence | 29 | $330,237 | $11,387 |
| Jakafi | 11 | $309,447 | $28,132 |
| Alecensa | 15 | $243,475 | $16,232 |
| Alvaiz | 22 | $171,764 | $7,807 |
| Xtandi | 14 | $170,019 | $12,144 |
| Promacta | 11 | $84,919 | $7,720 |
| Eliquis | 20 | $21,684 | $1,084 |
| Letrozole | 406 | $7,850 | $19 |
| Abiraterone Acetate | 24 | $3,482 | $145 |
| Exemestane | 43 | $3,149 | $73 |
| Anastrozole | 111 | $3,010 | $27 |
| Hydroxyurea | 44 | $1,728 | $39 |
| Entecavir | 40 | $1,053 | $26 |
| Dexamethasone | 52 | $950 | $18 |
| Granisetron | 13 | $607 | $47 |
| Gabapentin | 46 | $567 | $12 |
| Imatinib Mesylate | 11 | $560 | $51 |
| Potassium Chloride | 26 | $469 | $18 |
| Ondansetron | 53 | $455 | $9 |
| Prednisone | 25 | $311 | $12 |
| Metoclopramide | 14 | $274 | $20 |
| Tamoxifen Citrate | 11 | $252 | $23 |
| Sodium Polystyrene Sulfonate | 11 | $212 | $19 |
| Alendronate | 19 | $186 | $10 |
| Lidocaine Hcl Viscous | 12 | $126 | $11 |
Year by year
| 2024 | 1,510 | 306 | 1% (13) | 24% | $5,365,238 |
| 2023 | 1,342 | 294 | 1% (14) | 19% | $4,021,153 |
| 2022 | 1,228 | 256 | 1% (13) | None | $3,031,970 |
| 2021 | 1,033 | 234 | 2% (16) | 19% | $2,345,160 |
| 2020 | 1,041 | 209 | 3% (28) | 22% | $2,530,870 |
| 2019 | 825 | 189 | 2% (15) | 20% | $1,693,078 |
| 2018 | 586 | 126 | 5% (31) | 18% | $1,061,918 |
| 2017 | 429 | 133 | None | 14% | $346,025 |
| 2016 | 551 | 161 | 4% (23) | None | $228,449 |
| 2015 | 770 | 169 | 4% (28) | 14% | $485,579 |
| 2014 | 742 | 179 | 8% (58) | 19% | $355,320 |
| 2013 | 588 | 138 | 12% (69) | None | $297,916 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 25 drugs
| Lenalidomide | 68 | $783,543 | $11,523 |
| Ibrance | 47 | $659,697 | $14,036 |
| Tagrisso | 43 | $593,640 | $13,806 |
| Calquence | 35 | $411,268 | $11,751 |
| Promacta | 21 | $332,339 | $15,826 |
| Xtandi | 16 | $186,014 | $11,626 |
| Brukinsa | 14 | $179,622 | $12,830 |
| Kisqali | 12 | $174,882 | $14,574 |
| Nivestym | 13 | $10,526 | $810 |
| Letrozole | 449 | $7,816 | $17 |
| Exemestane | 57 | $4,533 | $80 |
| Abiraterone Acetate | 19 | $3,423 | $180 |
| Anastrozole | 123 | $2,918 | $24 |
| Hydroxyurea | 32 | $1,386 | $43 |
| Dexamethasone | 47 | $1,307 | $28 |
| Imatinib Mesylate | 12 | $643 | $54 |
| Entecavir | 13 | $585 | $45 |
| Acyclovir | 13 | $441 | $34 |
| Gabapentin | 30 | $396 | $13 |
| Potassium Chloride | 18 | $391 | $22 |
| Ondansetron | 38 | $322 | $8 |
| Prednisone | 24 | $253 | $11 |
| Venlafaxine | 15 | $249 | $17 |
| Alendronate | 15 | $155 | $10 |
| Metoclopramide | 12 | $118 | $10 |
2022: 21 drugs
| Ibrance | 55 | $721,452 | $13,117 |
| Revlimid | 35 | $600,999 | $17,171 |
| Promacta | 21 | $473,399 | $22,543 |
| Lenalidomide | 27 | $353,143 | $13,079 |
| Calquence | 23 | $306,426 | $13,323 |
| Letrozole | 404 | $7,736 | $19 |
| Exemestane | 53 | $4,470 | $84 |
| Enoxaparin | 16 | $4,201 | $263 |
| Abiraterone Acetate | 26 | $3,813 | $147 |
| Anastrozole | 137 | $3,013 | $22 |
| Dexamethasone | 38 | $2,158 | $57 |
| Hydroxyurea | 24 | $1,199 | $50 |
| Potassium Chloride | 20 | $702 | $35 |
| Imatinib Mesylate | 12 | $643 | $54 |
| Entecavir | 12 | $614 | $51 |
| Gabapentin | 42 | $541 | $13 |
| Ondansetron | 40 | $406 | $10 |
| Prednisone | 28 | $334 | $12 |
| Alendronate | 19 | $198 | $10 |
| Metoclopramide | 21 | $195 | $9 |
| Hydrocodone-Acetaminophen | 12 | $161 | $13 |
2021: 20 drugs
| Ibrance | 64 | $805,152 | $12,581 |
| Revlimid | 49 | $775,478 | $15,826 |
| Promacta | 12 | $260,573 | $21,714 |
| Calquence | 13 | $190,439 | $14,649 |
| Venclexta | 12 | $131,171 | $10,931 |
| Letrozole | 353 | $7,776 | $22 |
| Enoxaparin | 20 | $7,050 | $352 |
| Exemestane | 41 | $3,405 | $83 |
| Dexamethasone | 56 | $2,920 | $52 |
| Anastrozole | 104 | $2,327 | $22 |
| Imatinib Mesylate | 12 | $1,714 | $143 |
| Hydroxyurea | 27 | $1,564 | $58 |
| Entecavir | 12 | $871 | $73 |
| Tamoxifen Citrate | 16 | $858 | $54 |
| Acyclovir | 17 | $451 | $27 |
| Gabapentin | 25 | $323 | $13 |
| Ondansetron | 31 | $321 | $10 |
| Metoclopramide | 13 | $125 | $10 |
| Alendronate | 12 | $125 | $10 |
| Hydrocodone-Acetaminophen | 12 | $121 | $10 |
2020: 19 drugs
| Ibrance | 77 | $993,006 | $12,896 |
| Revlimid | 58 | $912,037 | $15,725 |
| Venclexta | 17 | $178,486 | $10,499 |
| Zarxio | 16 | $29,106 | $1,819 |
| Exemestane | 42 | $8,804 | $210 |
| Letrozole | 302 | $6,422 | $21 |
| Dexamethasone | 55 | $3,088 | $56 |
| Eliquis | 11 | $2,371 | $216 |
| Imatinib Mesylate | 13 | $2,089 | $161 |
| Anastrozole | 78 | $1,744 | $22 |
| Hydroxyurea | 29 | $1,540 | $53 |
| Tamoxifen Citrate | 23 | $1,160 | $50 |
| Acyclovir | 27 | $804 | $30 |
| Gabapentin | 18 | $271 | $15 |
| Hydrocodone-Acetaminophen | 21 | $251 | $12 |
| Mirtazapine | 17 | $244 | $14 |
| Ondansetron | 26 | $235 | $9 |
| Famotidine | 19 | $166 | $9 |
| Alendronate | 13 | $124 | $10 |
2019: 16 drugs
| Ibrance | 48 | $606,380 | $12,633 |
| Revlimid | 26 | $417,294 | $16,050 |
| Exemestane | 32 | $7,874 | $246 |
| Letrozole | 231 | $4,967 | $22 |
| Imatinib Mesylate | 11 | $3,135 | $285 |
| Entecavir | 24 | $2,670 | $111 |
| Dexamethasone | 41 | $1,974 | $48 |
| Hydroxyurea | 28 | $1,494 | $53 |
| Tamoxifen Citrate | 20 | $1,094 | $55 |
| Anastrozole | 40 | $851 | $21 |
| Mirtazapine | 21 | $373 | $18 |
| Gabapentin | 17 | $247 | $15 |
| Ondansetron | 21 | $189 | $9 |
| Alendronate | 14 | $153 | $11 |
| Prednisone | 11 | $150 | $14 |
| Temazepam | 14 | $143 | $10 |
2018: 17 drugs
| Ibrance | 27 | $332,422 | $12,312 |
| Revlimid | 12 | $185,932 | $15,494 |
| Tagrisso | 11 | $159,507 | $14,501 |
| Imatinib Mesylate | 11 | $5,894 | $536 |
| Exemestane | 19 | $3,889 | $205 |
| Letrozole | 143 | $2,828 | $20 |
| Hydroxyurea | 30 | $2,141 | $71 |
| Dexamethasone | 20 | $1,409 | $70 |
| Entecavir | 12 | $1,359 | $113 |
| Tamoxifen Citrate | 17 | $811 | $48 |
| Anastrozole | 21 | $540 | $26 |
| Ondansetron | 31 | $476 | $15 |
| Hydrocodone-Acetaminophen | 22 | $323 | $15 |
| Mirtazapine | 13 | $196 | $15 |
| Gabapentin | 12 | $143 | $12 |
| Lidocaine Hcl Viscous | 12 | $135 | $11 |
| Lorazepam | 13 | $92 | $7 |
2017: 10 drugs
| Imatinib Mesylate | 11 | $13,270 | $1,206 |
| Exemestane | 14 | $5,749 | $411 |
| Hydroxyurea | 23 | $1,551 | $67 |
| Anastrozole | 55 | $1,538 | $28 |
| Letrozole | 49 | $963 | $20 |
| Prednisone | 21 | $499 | $24 |
| Dexamethasone | 17 | $360 | $21 |
| Alendronate | 25 | $355 | $14 |
| Ondansetron | 21 | $345 | $16 |
| Gabapentin | 11 | $214 | $19 |
2016: 6 drugs
| Exemestane | 38 | $23,566 | $620 |
| Anastrozole | 217 | $7,269 | $33 |
| Hydroxyurea | 21 | $1,855 | $88 |
| Gabapentin | 11 | $759 | $69 |
| Alendronate | 44 | $610 | $14 |
| Prochlorperazine Maleate | 13 | $188 | $14 |
2015: 16 drugs
| Afinitor | 14 | $169,093 | $12,078 |
| Zytiga | 15 | $123,058 | $8,204 |
| Exemestane | 38 | $29,421 | $774 |
| Anastrozole | 276 | $8,706 | $32 |
| Hydroxyurea | 25 | $1,832 | $73 |
| Gabapentin | 32 | $1,790 | $56 |
| Hydrocodone-Acetaminophen | 18 | $971 | $54 |
| Tamoxifen Citrate | 11 | $597 | $54 |
| Acyclovir | 25 | $491 | $20 |
| Alendronate | 30 | $427 | $14 |
| Prednisone | 17 | $421 | $25 |
| Bicalutamide | 17 | $347 | $20 |
| Ondansetron | 21 | $347 | $17 |
| Dexamethasone | 13 | $228 | $18 |
| Lorazepam | 17 | $140 | $8 |
| Zolpidem | 13 | $84 | $6 |
2014: 21 drugs
| Afinitor | 12 | $128,040 | $10,670 |
| Tarceva | 12 | $78,426 | $6,535 |
| Exemestane | 29 | $17,341 | $598 |
| Lovenox | 15 | $11,082 | $739 |
| Anastrozole | 187 | $6,113 | $33 |
| Spiriva | 16 | $5,074 | $317 |
| Zenpep | 11 | $3,633 | $330 |
| Gabapentin | 17 | $1,211 | $71 |
| Hydroxyurea | 19 | $933 | $49 |
| Hydrocodone-Acetaminophen | 39 | $912 | $23 |
| Tamoxifen Citrate | 12 | $856 | $71 |
| Ondansetron | 30 | $479 | $16 |
| Prochlorperazine Maleate | 16 | $403 | $25 |
| Mirtazapine | 18 | $343 | $19 |
| Nystatin | 14 | $334 | $24 |
| Bicalutamide | 15 | $306 | $20 |
| Prednisone | 21 | $242 | $12 |
| Alendronate | 15 | $227 | $15 |
| Ciprofloxacin | 19 | $168 | $9 |
| Azithromycin | 12 | $127 | $11 |
| Levothyroxine | 11 | $119 | $11 |
2013: 13 drugs
| Tarceva | 22 | $134,363 | $6,107 |
| Exemestane | 16 | $5,882 | $368 |
| Fentanyl | 18 | $4,715 | $262 |
| Anastrozole | 113 | $4,029 | $36 |
| Gabapentin | 13 | $888 | $68 |
| Tamoxifen Citrate | 13 | $690 | $53 |
| Hydrocodone-Acetaminophen | 31 | $583 | $19 |
| Dexamethasone | 16 | $343 | $21 |
| Ondansetron | 22 | $342 | $16 |
| Pantoprazole | 12 | $286 | $24 |
| Prednisone | 18 | $200 | $11 |
| Prochlorperazine Maleate | 18 | $196 | $11 |
| Zolpidem | 11 | $77 | $7 |
Professional record
- NPI
- 1114180197
- Licence
- CA A103776California A103776: Current · expires 2027-11-30
- Trained
- Rush Medical College of Rush University, 2005
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0003X (207RH0003X)
- Mailing address
- 3430 E La Palma Ave, 6th Floor, Anaheim, CA, 92806
- NPI first listed
- 2008-07-09
- NPI last updated
- 2021-11-29
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.